Strut tissue coverage and endothelial cell coverage: A comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating

EuroIntervention

Volumn 6, Issue 5, 2010, Pages 630-637

  Soucy, Nicole V ^a   Feygin, Julia M ^a   Tunstall, Radhika ^a   Casey, Melissa A ^a   Pennington, Douglas E ^a   Huibregtse, Barbara A ^a   Barry, James J ^a  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Arterial stenting; Drug eluting stent; Endothelial cell; PECAM 1; Promus element; Stent coverage

Indexed keywords

CD31 ANTIGEN; CHROMIUM; EVEROLIMUS; PLATINUM; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; METAL; RAPAMYCIN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BARE METAL STENT; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING STENT; ENDOTHELIUM CELL; FEMALE; ILIAC ARTERY; NONHUMAN; QUANTITATIVE ANALYSIS; RABBIT; ANIMAL; CORONARY BLOOD VESSEL; PATHOLOGY; PHYSIOLOGY; PROSTHESIS; SCANNING ELECTRON MICROSCOPY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; ULTRASTRUCTURE;

ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; ANTIGENS, CD31; CHROMIUM; CORONARY VESSELS; DRUG-ELUTING STENTS; ENDOTHELIAL CELLS; FEMALE; IMMUNOSUPPRESSIVE AGENTS; METALS; MICROSCOPY, ELECTRON, SCANNING; PLATINUM; PROSTHESIS DESIGN; RABBITS; SIROLIMUS; STENTS;

EID: 79952279182     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I5A105     Document Type: Article

References (34)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R, Group RS. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80. (Pubitemid 34586912)
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23. (Pubitemid 37186209)
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31. (Pubitemid 38067635)
4. Serruys PW, Ong ATL, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, Hamm C, Otto-Terlouw PC. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention. 2005;1:58-65.
5. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Munzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation. 2006;114:798-806. (Pubitemid 44268230)
6. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008. (Pubitemid 46376800)
7. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202. (Pubitemid 43929240)
8. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27:1500-10. (Pubitemid 46986103)
9. Schwartz RS, Edelman ER, Carter A, Chronos N, Rogers C, Robinson KA, Waksman R, Weinberger J, Wilensky RL, Jensen DN, Zuckerman BD, Virmani R. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation. 2002;106:1867-73.
10. Boam AB. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective. Expert Rev Med Devices. 2006;3:297-300.
11. Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, Chronos NAF, Robinson KA, Waksman R, Weinberger J, Wilson GJ, Wilensky RL. Drug-eluting stents in preclinical studies. Updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Intervent. 2008;1:143-53.
12. Seifert PS, Huibregtse BA, Polovick J, Poff B. Early vascular response to overlapped paclitaxel-eluting stents in swine coronary arteries. Cardiovasc Revasc Med. 2007;8:251-8. (Pubitemid 350161453)
13. Wilson GJ, Polovick JE, Huibregtse BA, Poff BC. Overlapping paclitaxel- eluting stents: long-term effects in a porcine coronary artery model. Cardiovasc Res. 2007;76:361-72. (Pubitemid 350214456)
14. Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R. Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries. Circulation. 2009;120:141-49.
15. Perkins LEL, Boeke-Purkis KH, Wang Q, Stringer SK, Coleman LA. XIENCE V™ Everolimus-Eluting Coronary Stent System: A preclinical assessment. J Interven Cardiol. 2009;22:S28-S40.
16. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie F, Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52:333-42. (Pubitemid 352001347)
17. Simon C, Palmaz JC, Sprague EA. Influence of topography on endothelialization of stents: clues for new designs. J Long Term Eff Med Implants. 2000;10:143-51. (Pubitemid 30387812)
18. LaDisa JF, Jr., Olson LE, Douglas HA, Warltier DC, Kersten JR, Pagel PS. Alterations in regional vascular geometry produced by theoretical stent implantation influence distributions of wall shear stress: analysis of a curved coronary artery using 3D computational fluid dynamics modeling. Biomed Eng Online. 2006;5:40.
19. De Prado AP, Martinez CP, Ramon CC, Orden JM, Altonaga JR, Iglesias MJ, Purrinos MR, Orden MA, Marin JF, Fernandez-Vazquez F. Endothelialization of nonapposed stent struts located over the origin of a side branch: results with different carbofilm-coated stents. J Interv Cardiol. 2009;22:222-7.
20. O'Brien BJ, Stinson JS, Larsen SR, Eppihimer MJ, Carroll WJ. A platinum-chromium steel for cardiovascular stents. Biomaterials. 2010;31:3755-3761.
21. Allocco DJ, Cannon LA, Britt A, Heil JE, Nersesov A, Wehrenberg S, Dawkins KD, Kereiakes DJ. A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program. Trials. 2010;11:1.
22. Farb A, John M, Acampado E, Kolodgie FD, Prescott MF, Virmani R. Oral everolimus inhibits in-stent neointimal growth. Circulation. 2002;106:2379-84. (Pubitemid 35244741)
23. Guidelines on the clinical and non-clinical evaluations during the consultation procedure on medical substances contained in drug eluting (medical substance-eluting) coronary stents. EMEA/CHMP/EWP/110540/2007. http://www.emea.europa.eu/pdfs/human/ewp/11054007enfin.pdf.
24. Wilson GJ, Huibregtse BA, Stejskal EA, Crary J, Starzyk RM, Dawkins KD, Barry JJ. Vascular response to a third generation everolimus-eluting stent. EuroIntervention, 2010;6:512-519.
25. Chin-Quee SL, Hsu SH, Nguyen-Ehrenreich KL, Tai JT, Abraham GM, Pacetti SD, Chan YF, Nakazawa G, Kolodgie FD, Virmani R, Ding NN, Coleman LA. Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings. Biomaterials. 2010;31:648-657.
26. van Pelt-Verkuil E, Knoester J, van Pelt W, Brink M, Jense D, Emeis JJ. Time course of arterial repair following endothelial denudation in the rat carotid artery. Virchows Arch [Pathol Anat]. 1986;408:559-74.
27. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435-41. (Pubitemid 46717966)
28. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426-34. (Pubitemid 46717965)
29. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv. 2009;2:1035-46.
30. Ferns GA, Stewart-Lee AL, Anggard EE. Arterial response to mechanical injury: balloon catheter de-endothelialization. Atherosclerosis. 1992;92:89-104.
31. Doornekamp FN, Borst C, Post MJ. Endothelial cell recoverage and intimal hyperplasia after endothelium removal with or without smooth muscle cell necrosis in the rabbit carotid artery. J Vasc Res. 1996;33:146-55. (Pubitemid 26089632)
32. Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Clin Cancer Res. 2009;15:1612-22.
33. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Sukmawan R, Sadahira Y, Yoshida K. Visualization of neointima formation by optical coherence tomography. Int Heart J. 2005;46:1133-36.
34. Guagliumi G, Sirbu V. Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter Cardiovasc Interv. 2008;72:237-47.